C83.3Diffuse large B-cell lymphoma
Code usage status
Primary diagnosis
May be used as the primary diagnosis
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Complete code in the classification
Use when the diagnosis matches and no exclusion applies.
- Chapter II
- Neoplasms
- Group C00-C97
- Malignant neoplasms U ác tính
- Official Vietnamese name
- U lympho tế bào B lớn lan tỏa
- Additional WHO coding guidance
- Anaplastic diffuse large B-cell lymphoma CD30-positive diffuse large B-cell lymphoma Centroblastic diffuse large B-cell lymphoma Plasmablastic diffuse large B-cell lymphoma Immunoblastic diffuse large B-cell lymphoma Subtype not specified diffuse large B-cell lymphoma T-cell rich diffuse large B-cell lymphoma Excl.: mediastinal (thymic) large B-cell lymphoma (C85.2) mature T/NK-cell lymphomas (C84.-)
Related C83 codes
C83
Non-follicular lymphoma
C83.0
Primary diagnosis candidate
Small cell B-cell lymphoma
C83.1
Primary diagnosis candidate
Mantle cell lymphoma
C83.5
Primary diagnosis candidate
Lymphoblastic (diffuse) lymphoma
C83.7
Primary diagnosis candidate
Burkitt lymphoma
C83.8
Primary diagnosis candidate
Other non-follicular lymphoma
C83.9
Primary diagnosis candidate
Non-follicular (diffuse) lymphoma, unspecified
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
